|
Neoplasm Metastasis
|
0.050 |
Biomarker
|
phenotype |
BEFREE |
S100A11, a member of S100 calcium-binding protein family, is associated with the numerous processes of tumorigenesis and metastasis.
|
29375710 |
2018 |
|
Tumor Cell Invasion
|
0.050 |
Biomarker
|
phenotype |
BEFREE |
We investigated the effect of silencing S100A11 on TGF-β1-induced epithelial-mesenchymal transition (EMT), cell migration and invasion.
|
29569474 |
2018 |
|
Tumor Cell Invasion
|
0.050 |
Biomarker
|
phenotype |
BEFREE |
This study aimed to identify the function of S100A11 associated with cell proliferation and invasion in gastric cancer.
|
30662594 |
2018 |
|
Neoplasm Metastasis
|
0.050 |
Biomarker
|
phenotype |
BEFREE |
Four of these (AHNAK, septin-9, eIF4E, and S100A11) are shown to be essential for pseudopod protrusion and tumor cell migration and invasion.
|
20388789 |
2010 |
|
Tumor Cell Invasion
|
0.050 |
Biomarker
|
phenotype |
BEFREE |
Four of these (AHNAK, septin-9, eIF4E, and S100A11) are shown to be essential for pseudopod protrusion and tumor cell migration and invasion.
|
20388789 |
2010 |
|
Tumor Cell Invasion
|
0.050 |
Biomarker
|
phenotype |
BEFREE |
In human bladder cancer, overexpression of S100A4, S100A8 or S100A11 are associated with stage progression, invasion, metastasis and poor survival.
|
17523080 |
2007 |
|
Neoplasm Metastasis
|
0.050 |
AlteredExpression
|
phenotype |
LHGDN |
S100A11 gene expression was clearly up-regulated in specimens from patients with lymph node metastases relative to those from patients without lymph node metastases.
|
15138568 |
2004 |
|
Carcinogenesis
|
0.040 |
Biomarker
|
phenotype |
BEFREE |
S100A11 (calgizzarin), a member of the S100 family, is associated with oncogenesis, inflammation and myocardial damage.
|
30684913 |
2019 |
|
Carcinogenesis
|
0.040 |
Biomarker
|
phenotype |
BEFREE |
Our results suggested that S100A11 could activate the PI3K/Akt/mTOR signaling pathway in HSCC tumorigenesis.
|
31312359 |
2019 |
|
Carcinogenesis
|
0.040 |
Biomarker
|
phenotype |
BEFREE |
S100A11, a member of S100 calcium-binding protein family, is associated with the numerous processes of tumorigenesis and metastasis.
|
29375710 |
2018 |
|
Carcinogenesis
|
0.040 |
Biomarker
|
phenotype |
BEFREE |
Collectively, our results demonstrated that EIF3C overexpression is a potential target of angiogenesis for treatment with exosome inhibitor or S100A11 reduction to suppress HCC angiogenesis and tumorigenesis.
|
29568350 |
2018 |
|
Adenocarcinoma
|
0.040 |
AlteredExpression
|
group |
BEFREE |
Among the three subtypes, S100A11 levels were significantly higher in adenocarcinomas with KRAS mutations and strong proliferating activity.
|
26544866 |
2015 |
|
Adenocarcinoma
|
0.040 |
Biomarker
|
group |
BEFREE |
Further immunohistochemistry staining was positive for S100A11 only in non-small cell lung cancer (NSCLC) (ADC, SCC, large cell carcinomas, et al.), but not SCLC.
|
21861103 |
2012 |
|
Adenocarcinoma
|
0.040 |
AlteredExpression
|
group |
BEFREE |
Real-time reverse transcription-PCR analysis of human colorectal cancer cell lines and adenocarcinomas revealed that altered expression levels were also observed for six of the genes Igfbp5, Lcn2, Ly6d, N4wbp4 (PMEPA1), S100c, and Sox4.
|
15665292 |
2005 |
|
Adenocarcinoma
|
0.040 |
AlteredExpression
|
group |
BEFREE |
In benign prostatic hyperplasia (n=30) and benign tissue adjacent to adenocarcinoma (n=54), S100A11 expression was significantly higher in basal cells compared with in luminal cells (P <0.001).
|
15668896 |
2004 |
|
Intrahepatic Cholangiocarcinoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
Our results showed that S100A11 was obviously increased in ICC tumor tissues.
|
30182496 |
2019 |
|
Malignant neoplasm of pancreas
|
0.030 |
Biomarker
|
disease |
BEFREE |
We explored the role of S100A11 in the proliferation and apoptosis of pancreatic cancer cell line PANC-1 and the potential mechanisms involving the TGF-β<sub>1</sub>/SMAD4/p21 pathway.
|
29922945 |
2019 |
|
Malignant neoplasm of pancreas
|
0.030 |
Biomarker
|
disease |
BEFREE |
Extracellular S100A11 Plays a Critical Role in Spread of the Fibroblast Population in Pancreatic Cancers.
|
30850029 |
2019 |
|
Secondary malignant neoplasm of lymph node
|
0.030 |
Biomarker
|
disease |
BEFREE |
The nomograms comprising LNM and S100A11 achieved better predictive accuracy compared with TNM staging system for OS and RFS prediction.
|
30182496 |
2019 |
|
Secondary malignant neoplasm of lymph node
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
S100A11 expression was positively correlated with the FIGO stage and lymph node metastasis of CSCC patients (P < 0.05).
|
31695426 |
2019 |
|
Malignant neoplasm of breast
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
S100A11 overexpression has been reported in a number of cancers including papillary thyroid carcinoma, colon, pancreatic, and breast cancer.
|
30662594 |
2018 |
|
Malignant neoplasm of stomach
|
0.030 |
Biomarker
|
disease |
BEFREE |
This study aimed to identify the function of S100A11 associated with cell proliferation and invasion in gastric cancer.
|
30662594 |
2018 |
|
Papillary thyroid carcinoma
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
S100A11 overexpression has been reported in a number of cancers including papillary thyroid carcinoma, colon, pancreatic, and breast cancer.
|
30662594 |
2018 |
|
Intrahepatic Cholangiocarcinoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
S100A11 promotes TGF-β1-induced epithelial-mesenchymal transition through SMAD2/3 signaling pathway in intrahepatic cholangiocarcinoma.
|
29569474 |
2018 |
|
Malignant neoplasm of pancreas
|
0.030 |
Biomarker
|
disease |
BEFREE |
Immunohistochemical analyses of S100A11 and phosphorylated (p)-AKT serine/threonine kinase (AKT) were performed in 30 resected specimens from patients with pancreatic cancer.
|
29375710 |
2018 |